Altmetric

Chronic obstructive pulmonary disease and myocardial infarction: effects on presentation, management and outcomes

File Description SizeFormat 
ehj qcco paper 1.0.docxAccepted version605.77 kBMicrosoft WordView/Open
ehjqcco.qcw005.full.pdfPublished version445.44 kBAdobe PDFView/Open
Title: Chronic obstructive pulmonary disease and myocardial infarction: effects on presentation, management and outcomes
Authors: Rothnie, K
Quint, JK
Item Type: Journal Article
Abstract: Cardiovascular disease is a common cause of death in patients with chronic obstructive pulmonary disease (COPD) and is a key target for improving outcomes. However, there are concerns that patients with COPD may not have enjoyed the same mortality reductions from acute myocardial infarction (AMI) in recent decades as the general population. This has generated interest in how COPD patients present with AMI and how their management and outcomes compare to non-COPD patients. The evidence points to an increased risk of death after AMI in patients with COPD, but it is unclear to what extent this is attributable to COPD itself or to modifiable factors including under-treatment with guideline-recommended interventions and drugs. We review the evidence for differences between COPD and non-COPD patients in terms of the presentation of AMI, its treatment and outcomes both in-hospital and in the longer term.
Issue Date: 4-Feb-2016
Date of Acceptance: 22-Jan-2016
URI: http://hdl.handle.net/10044/1/29088
DOI: 10.1093/ehjqcco/qcw005
ISSN: 2058-5225
Publisher: Oxford University Press
Start Page: 81
End Page: 90
Journal / Book Title: European Heart Journal- Quality of Care and Clinical Outcomes
Volume: 2
Issue: 2
Copyright Statement: © The Author 2016. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Sponsor/Funder: GlaxoSmithKline Services Unlimited
Funder's Grant Number: PO #3000555261
Publication Status: Published
Open Access location: http://ehjqcco.oxfordjournals.org/content/early/2016/02/25/ehjqcco.qcw005
Appears in Collections:National Heart and Lung Institute
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx